Patent Application for Implantable Sensors and Shunting Systems

ChangeBridge: Patent Apps - Medical Devices (A61M)

Detected March 26th, 2026

Summary

The USPTO has published a new patent application (US20260083946A1) for implantable sensors and shunting systems. The application details a system for shunting blood between heart atria and includes a sensor with an actuation element to reduce tissue ingrowth. The filing date was December 3, 2025.

View original document View source feed page

What changed

This document is a publication of a patent application filed with the USPTO, specifically application US20260083946A1, titled 'IMPLANTABLE SENSORS AND ASSOCIATED SYSTEMS AND METHODS'. The application describes a system for interatrial shunting, including a shunting element and an operably coupled sensor with an actuation mechanism designed to mitigate tissue ingrowth. The inventors listed are Brian Fahey, Amr Salahieh, Marwan Berrada, Tom Saul, and Peter Andriola.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signifies potential future intellectual property developments in the medical device sector, particularly concerning cardiovascular implants and monitoring systems. Companies operating in this space should be aware of this filing as it may impact future product development and patent landscapes.

Source document (simplified)

← USPTO Patent Applications

IMPLANTABLE SENSORS AND ASSOCIATED SYSTEMS AND METHODS

Application US20260083946A1 Kind: A1 Mar 26, 2026

Inventors

Brian Fahey, Amr Salahieh, Marwan Berrada, Tom Saul, Peter Andriola

Abstract

The present technology relates to interatrial shunting systems and methods. In some embodiments, the present technology includes a system for shunting blood between a left atrium and a right atrium of a patient. The system can include a shunting element having a lumen extending therethrough. The lumen is configured to fluidly couple the left atrium and the right atrium when the shunting element is implanted in the patient. The system can also include a sensor configured to be implanted in the patient and operably coupled to the shunting element. An actuation element is coupled to the sensor. The actuation element is configured to be selectively energized and transmit a desired motion to the sensor to reduce the likelihood of tissue ingrowth/overgrowth and adhesion on at least a portion of the sensor.